Complementing T-cell Function: An Inhibitory Role of the Complement System in T-cell-Mediated Antitumor Immunity

Area of Science:

• Immunology
• Oncology
• Complement System Biology

Background:

• CD8(+) T cells are crucial for anti-tumor immunity.
• The complement system's role in cancer immunity is complex and multifaceted.
• Immune checkpoint blockade (ICB) has revolutionized cancer treatment but has limitations.

Discussion:

• Complement component 3 (C3) was identified as a suppressor of CD8(+) tumor-infiltrating T cells.
• C3 exerts its suppressive function by inhibiting interleukin-10 (IL10) production.
• Complement receptors, specifically C3aR and C5aR, act as coinhibitory receptors on T cells.

Key Insights:

• Targeting C3aR and C5aR in conjunction with ICB significantly enhances anti-tumor activity.
• This study elucidates a novel mechanism by which the complement system regulates anti-tumor T-cell responses.
• Complement receptors are redefined as critical regulators of T-cell function within the tumor microenvironment.

Outlook:

• These findings offer a new therapeutic avenue for improving cancer immunotherapy efficacy.
• Strategies targeting complement receptors may overcome resistance to current ICB therapies.
• Further research into complement-T cell interactions could lead to next-generation cancer treatments.